EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 9

He shou wu (fo-ti) Pleuropterus multiflorus (Thunb.) Turcz. ex Nakai

Also called: fo-ti, Reynoutria multiflora (synonym), Fallopia multiflora (synonym), Polygonum multiflorum (synonym), Shou Wu Pian, Chinese climbing knotweed

He shou wu (fo-ti) is a climbing plant native to China and northern Indochina whose tuberous root is used in traditional Chinese medicine, including for graying hair. LiverTox rates it a well-established cause of liver injury, which is occasionally fatal.

Category
Botanical
Part used
Root, raw or "prepared" (processed) root; the stem is a separate traditional ingredient
Strongest evidence
C Limited
Native range
Native to China, Taiwan and northern Indochina (POWO: "China to N. Indo-China, Taiwan")
Reviewed
2026-10-29

Class 3 Limited studies in people. No randomized trial of he shou wu alone was found in PubMed. The human data are non-randomized, such as a prospective cohort of 72 outpatients taking it for 4 weeks with liver-test monitoring. [3]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

2 topics studied2 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what He shou wu (fo-ti) does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for He shou wu (fo-ti), evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood lipids, aging and neurodegenerative diseaseCA 2019 review notes several clinical studies in dyslipidemia and neurodegenerative diseases but gives no effect sizes; it emphasizes the rising number of liver-injury reports. [6]
Liver injury risk in users (prospective cohort)COf 72 outpatients taking he shou wu for 4 weeks, 6 developed asymptomatic transaminase rises: 37.5% of HLA-B*35:01 carriers versus 4.7% of non-carriers. [3]

Main constituents: More than 100 compounds; the major groups are stilbenes (notably 2,3,5,4'-tetrahydroxystilbene-2-O-glucoside), quinones (anthraquinones such as emodin and rhein) and flavonoids [4]

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    See details

    LiverTox likelihood category A (well-established cause of clinically apparent liver injury); hepatocellular or mixed injury within days to 6 months …

    Details and sources
  • Pregnancy and breastfeeding
    A 2015 review lists embryonic toxicity among the adverse effects of Polygonum multiflorum extracts.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    1 found

    Each names the exact material tested, which may differ from a supplement.

    Details and sources
  • FDA new dietary ingredient notifications
    2 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • LiverTox likelihood category A: a well-established cause of clinically apparent liver injury. Injury is usually self-limited but can be prolonged and is occasionally fatal. In China it is reported as the most common cause of herbal liver injury. [1]
  • Onset usually ranges from a few days to about 6 months, with a pattern resembling acute viral hepatitis; up to 10% of clinically apparent cases have been fatal or led to urgent liver transplantation. [1]
  • Liver injury commonly recurs, faster, when the herb is restarted, so rechallenge should be avoided. [1]
  • The HLA-B*35:01 allele is a genetic risk factor: in a pilot study it was found in 45.4% of 11 patients with he shou wu liver injury versus 2.7% of the Han Chinese population. [3]
  • Australia's TGA received reports of nine cases of liver damage in people taking products containing the herb between 2008 and 2018, and requires a liver warning on listed oral medicines. [2]
  • A systematic review of 31 liver-injury cohort studies named Polygonum multiflorum among the main herbs causing herb-induced liver injury. [5]
  • A 2015 review also lists nephrotoxicity and embryonic toxicity among adverse effects of extracts, attributed to quinones such as emodin and rhein. [4]
Quality

Identity, quality and standardization

  • A 2015 review records nine adulterant species from six plant families used in place of he shou wu. [4]
  • Reviewers identify quality control as one of the major safety problems for he shou wu products. [6]
Regulation

Regulatory status

  • Australia: listed oral medicines must carry the warning "Fallopia multiflora may harm the liver in some people. Use under the supervision of a healthcare professional." (TGA, April 2019). [2]
  • Canada: Health Canada's TCM Ingredients monograph (May 29, 2026) requires the ingredient database's risk statements for raw and prepared Reynoutria multiflora root. [8]
  • US: FDA states that, by law, it does not approve dietary supplements before they are marketed; firms are responsible for the safety and labeling of their products. [9]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • 2,3,5,4'-Tetrahydroxystilbene-2-O-glucoside Stilbenes [P5]
  • Anthraquinones including chrysophanol, emodin and rhein (LiverTox: liver injury is usually attributed to anthraquinones such as emodin; the mechanism is not known) Anthraquinones [P3]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 2 entries naming Polygonum multiflorum or Radix Polygoni Multiflori, both multi-ingredient combinations (earliest NDI 197 submitted 2003-01-22; most recent NDI 550 submitted 2008-07-17). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC classification of he shou wu (Pleuropterus multiflorus / Polygonum multiflorum root) was found in the IARC Monographs list of classifications (Volumes 1–142, list updated 2026-07-23; checked 2026-10-29). [P2]
  • No NTP technical report (2-year study) on he shou wu (Pleuropterus multiflorus / Polygonum multiflorum root) was found in NTP's list of technical reports (checked 2026-10-29). [P10]
  • Its constituent emodin (pure compound, 2-year feed studies, NTP TR-493, 2001): no evidence of carcinogenic activity in male rats and female mice; equivocal evidence in female rats (Zymbal's gland carcinoma) and male mice (renal tubule neoplasms). This is not an evaluation of the herb. [P9]

Liver (NIH LiverTox)

  • LiverTox likelihood category A (well-established cause of clinically apparent liver injury); hepatocellular or mixed injury within days to 6 months; up to 10% of clinically apparent cases fatal or requiring urgent transplant (chapter updated August 18, 2020). [P3]
  • HLA-B*35:01 carriers had higher incidence of transaminase rises in a prospective cohort (37.5% vs 4.7%; relative risk 8.0). [P4]
  • Australia's TGA received nine reports of liver damage with products containing the herb between 2008 and 2018 and requires a liver warning on listed oral medicines (April 2019). [P6]
  • A systematic review of 31 cohort studies named Polygonum multiflorum among the main herbs causing herb-induced liver injury. [P7]

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • A 2015 review records nine adulterant species from six families used as he shou wu. [P5]

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) unless FDA grants an exemption petition under 111.75(a)(1)(ii) [P8]
  • Species identity versus reported adulterant species — Nine adulterant species from six families reported [P5]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • A 2015 review lists embryonic toxicity among the adverse effects of Polygonum multiflorum extracts. [P5]

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  3. LiverTox (NIDDK). Polygonum Multiflorum (last update August 18, 2020), 2020-08-18. ncbi.nlm.nih.gov
  4. Li C, et al. HLA-B*35:01 allele is a potential biomarker for predicting Polygonum multiflorum-induced liver injury in humans. Hepatology 2019;70(1):346-357 (PMID 30985007), 2019-07. pubmed.ncbi.nlm.nih.gov
  5. Lin L, et al. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review. J Ethnopharmacol 2015;159:158-83 (PMID 25449462), 2015-01-15. pubmed.ncbi.nlm.nih.gov
  6. Therapeutic Goods Administration (Australia). Fallopia multiflora (he shou wu): safety advisory - potential for liver damage (29 April 2019), 2019-04-29. tga.gov.au
  7. Byeon JH, et al. Systematic review of published data on herb induced liver injury. J Ethnopharmacol 2019;233:190-196 (PMID 30639232), 2019-04-06. pubmed.ncbi.nlm.nih.gov
  8. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  9. National Toxicology Program. TR-493: Toxicology and Carcinogenesis Studies of Emodin (CASRN 518-82-1) in F344/N Rats and B6C3F1 Mice (Feed Studies) (June 2001), 2001-06. ntp.niehs.nih.gov
  10. National Toxicology Program. Technical Reports (list of TR studies; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
Sources

Sources

  1. LiverTox (NIDDK). Polygonum Multiflorum (last update August 18, 2020), 2020-08-18. ncbi.nlm.nih.gov
  2. Therapeutic Goods Administration (Australia). Fallopia multiflora (he shou wu): safety advisory - potential for liver damage (29 April 2019), 2019-04-29. tga.gov.au
  3. Li C, et al. HLA-B*35:01 allele is a potential biomarker for predicting Polygonum multiflorum-induced liver injury in humans. Hepatology 2019;70(1):346-357 (PMID 30985007), 2019-07. pubmed.ncbi.nlm.nih.gov
  4. Lin L, et al. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review. J Ethnopharmacol 2015;159:158-83 (PMID 25449462), 2015-01-15. pubmed.ncbi.nlm.nih.gov
  5. Byeon JH, et al. Systematic review of published data on herb induced liver injury. J Ethnopharmacol 2019;233:190-196 (PMID 30639232), 2019-04-06. pubmed.ncbi.nlm.nih.gov
  6. Liu Y, et al. Polygonum multiflorum-induced liver injury: clinical characteristics, risk factors, material basis, action mechanism and current challenges. Front Pharmacol 2019;10:1467 (PMID 31920657), 2019-12-13. pubmed.ncbi.nlm.nih.gov
  7. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Pleuropterus multiflorus (Thunb.) Turcz. ex Nakai; WCVP synonyms include Reynoutria multiflora, Fallopia multiflora and Polygonum multiflorum (accessed 2026-10-29; native range: "China to N. Indo-China, Taiwan"), 2026-10-29. powo.science.kew.org
  8. Health Canada, NNHPD. Traditional Chinese Medicine Ingredients monograph (date May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
  9. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.